Exenatide (exendin-4) clinical trials: 194 trials
Page 2 of 4
- The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
NCT03151005 · Phase 4 · Completed
Posted results
- Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
NCT02417142 · Phase 4 · Completed
Posted results
- Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
NCT00097500 · Phase 3 · Completed
Posted results
- An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
NCT00516048 · Phase 3 · Completed
Posted results
- Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
NCT02251431 · Phase 3 · Completed
Posted results
- Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
NCT00845507 · Phase 4 · Completed
Posted results
- A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
NCT00516074 · Phase 3 · Completed
Posted results
- The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
NCT00546728 · Phase 4 · Completed
Posted results
- Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
NCT00845182 · Phase 4 · Completed
Posted results
- Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
NCT02664441 · Phase 3 · Completed
Posted results
- The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
NCT00456885 · Phase 4 · Completed
Posted results
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
NCT00667732 · Phase 4 · Completed
Posted results
- Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
NCT00736229 · Phase 4 · Completed
Posted results
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
NCT01269047 · Phase 4 · Completed
Posted results
- Bioenergetic Alterations After Exenatide Administration
NCT00623545 · Phase 4 · Completed
Posted results
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
NCT01006889 · Phase 4 · Completed
Posted results
- Effect of Exenatide on Liver and Heart Fat and Inflammation
NCT01951651 · Phase 4 · Completed
Posted results
- Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
NCT01432405 · Phase 4 · Completed
Posted results
- Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
NCT00679042 · Phase 3 · Active, not recruiting
Posted results
- Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
NCT02104739 · Phase 4 · Completed
Posted results
- Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
NCT02160990 · Phase 4 · Completed
Posted results
- GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
NCT03029351 · Phase 4 · Terminated
Posted results
- Acute Effect of Exenatide on Brain Glucose Metabolism
NCT01588418 · Phase 4 · Completed
Posted results
- Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
NCT01381926 · Phase 4 · Terminated
Posted results
- New Onset Type 1 Diabetes: Role of Exenatide
NCT01269034 · Phase 4 · Completed
Posted results
- Intravenous Exenatide in Patients With Acute Brain Injury
NCT02058940 · Phase 4 · Completed
Posted results
- Role of Exenatide in NASH-a Pilot Study
NCT00650546 · Phase 2/3 · Completed
Posted results
- Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
NCT01791465 · Phase 4 · Terminated
Posted results
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
NCT02802514 · Phase 4 · Terminated
Posted results
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
NCT02793154 · Phase 4 · Terminated
Posted results
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
NCT00799435 · Phase 4 · Terminated
Posted results
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
NCT00717457 · Phase 3 · Completed
Linked paper with results
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
NCT00035984 · Phase 3 · Completed
Linked paper with results
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
NCT00324363 · Phase 3 · Completed
Linked paper with results
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
NCT00111540 · Phase 3 · Completed
Linked paper with results
- COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
NCT02404376 · Phase 3 · Completed
Linked paper with results
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
NCT00039026 · Phase 3 · Completed
Linked paper with results
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
NCT00359879 · Phase 3 · Completed
Linked paper with results
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
NCT00313001 · Phase 3 · Completed
Linked paper with results
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
NCT00039013 · Phase 3 · Completed
Linked paper with results
- Safety and Efficacy of Exenatide as Monotherapy
NCT00381342 · Phase 3 · Completed
Linked paper with results
- Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
NCT03297879 · Phase 4 · Completed
Linked paper with results
- Research of Exenatide for Overweight/Obese PCOS Patients With IGR
NCT03352869 · Phase 4 · Completed
Linked paper with results
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
NCT00099320 · Phase 3 · Completed
Linked paper with results
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
NCT01270191 · Phase 4 · Status unknown
Linked paper with results
- Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
NCT00044668 · Phase 3 · Completed
Linked paper with results
- Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
NCT02162550 · Phase 4 · Status unknown
Linked paper with results
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
NCT00099619 · Phase 3 · Completed
Linked paper with results
- Myocardial Protection of Exenatide in AMI
NCT01580514 · Phase 4 · Completed
Linked paper with results
- Exenatide for Stress Hyperglycemia
NCT01969149 · Phase 2/3 · Completed
Linked paper with results